PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Gastroenterology, Veterans Affairs Puget Sound Healthcare System, University of Washington, Seattle.\', \'Research and Development, Veterans Affairs Puget Sound Health Care System, Seattle, Washington.\', \'Division of Pulmonary, Critical Care, and Sleep, Veterans Affairs Puget Sound Healthcare System, University of Washington, Seattle.\', \'Division of Nephrology, Veterans Affairs Puget Sound Healthcare System, University of Washington, Seattle.\', \'Department of Veterans Affairs, Population Health Services, Palo Alto Healthcare System, Palo Alto, California.\', \'Division of Allergy and Infectious Diseases, Veterans Affairs Puget Sound Healthcare System, University of Washington, Seattle.\', \'Veterans Affairs Palo Alto Healthcare System, Palo Alto, California.\', \'Department of Radiology, Stanford University School of Medicine, Stanford, California.\', \'Paul G. Allen School of Computer Science and Engineering, University of Washington, Seattle.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1001/jamanetworkopen.2021.4347
?:doi
?:hasPublicationType
?:journal
  • JAMA network open
is ?:pmid of
?:pmid
?:pmid
  • 33822066
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Development of COVIDVax Model to Estimate the Risk of SARS-CoV-2-Related Death Among 7.6 Million US Veterans for Use in Vaccination Prioritization.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all